Wyeth phases out NY facility
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing at its US facility as part of its consolidation plans, which will see the gradual phasing out of all operations at the New York facility by late 2008.
Pharmaceutical manufacturers, Wyeth, are to phase out manufacturing at its US facility as part of its consolidation plans, which will see the gradual phasing out of all operations at the New York facility by late 2008.
Cargill-Cerestar is to unveil a new excipient developed on the back of a directly compressible excipient platform that allows tablets to be produced using lower compression forces.
Materials company, Micromuscle, has developed an electro-active polymer technology that allows the controlled release of liquid medications that reflect an emerging class of advanced materials with new revolutionary properties.
Dynatek dalta Scientific Instruments are to introduce its drug-eluting stent tester to audiences throughout the US and Europe, signifying the first time a coating durability tester for medical devices has been commercially available.
Freeman Technology introduces its new aeration control unit for its FT4 Powder Rheometer, which allows airflow control through a powder under test, enabling the automated measurement of the powder's flow properties.